Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedFeb 25, 2024
DataAggregated Company Financials
Companies23
  • 7D1.1%
  • 3M6.8%
  • 1Y-1.6%
  • YTD0.0%

In the last week, the Pharma industry is up 1.1%, with AstraZeneca up 1.2%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 15% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 25 Feb 2024UK£236.1bUK£70.6bUK£9.6b33.7x24.5x3.3x
Tue, 23 Jan 2024UK£238.9bUK£68.9bUK£10.7b36.6x22.4x3.5x
Thu, 21 Dec 2023UK£232.9bUK£69.1bUK£10.7b34.9x21.8x3.4x
Sat, 18 Nov 2023UK£227.8bUK£69.8bUK£10.8b53.7x21.1x3.3x
Mon, 16 Oct 2023UK£245.7bUK£70.8bUK£10.4b56.6x23.7x3.5x
Wed, 13 Sep 2023UK£239.5bUK£69.7bUK£10.3b53.5x23.4x3.4x
Fri, 11 Aug 2023UK£244.0bUK£69.0bUK£10.2b52.8x24x3.5x
Sun, 09 Jul 2023UK£223.4bUK£67.4bUK£7.8b52.7x28.5x3.3x
Tue, 06 Jun 2023UK£252.0bUK£68.6bUK£8.0b55.5x31.6x3.7x
Thu, 04 May 2023UK£257.4bUK£68.3bUK£8.0b55.7x32.4x3.8x
Sat, 01 Apr 2023UK£243.3bUK£69.5bUK£6.9b51.9x35.3x3.5x
Mon, 27 Feb 2023UK£243.1bUK£70.7bUK£7.1b54.8x34.3x3.4x
Wed, 25 Jan 2023UK£235.4bUK£79.3bUK£6.3b38.6x37.4x3x
Fri, 23 Dec 2022UK£246.4bUK£80.3bUK£6.3b37.7x38.8x3.1x
Sun, 20 Nov 2022UK£235.9bUK£80.6bUK£6.4b26.5x37.1x2.9x
Tue, 18 Oct 2022UK£217.1bUK£81.0bUK£3.7b20.3x59.4x2.7x
Thu, 15 Sep 2022UK£222.9bUK£79.7bUK£3.7b15.6x60.4x2.8x
Sat, 13 Aug 2022UK£237.6bUK£77.8bUK£3.8b14.9x63.2x3.1x
Mon, 11 Jul 2022UK£273.7bUK£75.1bUK£4.5b16.5x60.2x3.6x
Wed, 08 Jun 2022UK£258.4bUK£73.5bUK£4.6b17.3x56.4x3.5x
Fri, 06 May 2022UK£265.9bUK£74.2bUK£4.6b17.6x58.2x3.6x
Sun, 03 Apr 2022UK£255.4bUK£66.6bUK£4.8b20.1x53.2x3.8x
Tue, 01 Mar 2022UK£241.0bUK£65.9bUK£4.8b30.7x50.7x3.7x
Thu, 27 Jan 2022UK£230.0bUK£61.3bUK£5.6b31.9x40.8x3.7x
Sat, 25 Dec 2021UK£233.6bUK£61.6bUK£5.6b32.1x41.4x3.8x
Mon, 22 Nov 2021UK£227.9bUK£61.6bUK£5.8b24.3x39.5x3.7x
Wed, 20 Oct 2021UK£226.2bUK£58.1bUK£7.5b27.2x30.3x3.9x
Fri, 17 Sep 2021UK£216.9bUK£58.2bUK£7.5b28.9x28.9x3.7x
Sun, 15 Aug 2021UK£226.6bUK£58.1bUK£7.5b27x30.2x3.9x
Thu, 10 Jun 2021UK£190.4bUK£56.2bUK£8.5b26.8x22.4x3.4x
Wed, 03 Mar 2021UK£166.1bUK£57.2bUK£8.3b33.9x20.1x2.9x
Price to Earnings Ratio

20.1x


Total Market Cap: UK£166.1bTotal Earnings: UK£8.3bTotal Revenue: UK£57.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 37.9x202220232024
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.5x which is lower than its 3-year average PE of 37.9x.
  • The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 5.3% per year over the last three years.
  • Revenues for these companies have grown 7.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market-0.24%
Healthcare1.03%
Pharma1.06%
Pharma1.06%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£102.201.2%
+UK£2.0b
-7.9%PE33.7x
INDV IndiviorUK£16.8720.2%
+UK£380.7m
11.1%PE1445.7x
HIK Hikma PharmaceuticalsUK£20.744.4%
+UK£191.2m
20.8%PE30.6x
HCM HUTCHMED (China)UK£2.477.2%
+UK£140.8m
-7.1%PS3.5x
APH Alliance PharmaUK£0.458.9%
+UK£19.7m
-33.4%PS1.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

INDV

UK£16.87

Indivior

7D

20.2%

1Y

11.1%

STX

UK£0.029

Shield Therapeutics

7D

-51.3%

1Y

-63.0%

AZN

UK£102.20

AstraZeneca

7D

1.2%

1Y

-7.9%

POLB

UK£0.10

Poolbeg Pharma

7D

-9.2%

1Y

16.3%

GSK

UK£16.72

GSK

7D

-0.2%

1Y

15.7%

SAR

UK£0.38

Sareum Holdings

7D

15.4%

1Y

-63.4%

REDX

UK£0.18

Redx Pharma

7D

-5.1%

1Y

-60.2%

EAH

UK£0.94

ECO Animal Health Group

7D

-8.1%

1Y

-26.5%

AGY

UK£0.026

Allergy Therapeutics

7D

6.1%

1Y

n/a

HCM

UK£2.47

HUTCHMED (China)

7D

7.2%

1Y

-7.1%

FUM

UK£0.39

Futura Medical

7D

-13.5%

1Y

-27.4%

DPH

UK£38.66

Dechra Pharmaceuticals

7D

0.2%

1Y

32.4%

CEL

UK£1.10

Celadon Pharmaceuticals

7D

-2.2%

1Y

103.7%

MAX

UK£0.05

MaxRets Ventures

7D

-75.0%

1Y

-80.0%